Published in Cancer Weekly, January 23rd, 2007
The study consisted of 44,630 men between the ages of 65 and 80 and found that those patients who chose to treat their prostate cancer were 30% less likely to die than those who waited. This suggests that all patients with localized disease regardless of age should consider definitive treatments rather than "watchful waiting." It is estimated that approximately 30,000 of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.